Anticoagulants, Antiplatelets, and Thrombolytics

Highlights of Latest Advances in Antithrombotics Shaker A. Mousa Antiplatelet, Anticoagulant, and Thrombolytic Drug Interactions Omer Iqbal and Shaker A. Mousa Evaluation of Platelet Antagonists in In Vitro Flow Models of Thrombosis Owen J. T. McCarty, James P. Abulencia, Shaker A. Mousa, and Konstantinos Konstantopoulos Heparin and Low Molecular Weight Heparin in Thrombosis, Cancer, and Inflammatory Diseases Shaker A. Mousa Are Low Molecular Weight Heparins the Same? Shaker A. Mousa Antithrombotic Drugs for the Treatment of Heparin-Induced Thrombocytopenia Walter P. Jeske and Jeanine M. Walenga Laboratory Methods for Heparin-Induced Thrombocytopenia Margaret Prechel, Walter P. Jeske, and Jeanine M. Walenga Factor Xa Inhibitors Jeanine M. Walenga, Walter P. Jeske, Debra Hoppensteadt, and Jawed Fareed Tissue Factor/VIIa in Thrombosis and Cancer Shaker A. Mousa Tissue Factor Pathway Inhibitor in Thrombosis and Beyond Shaker A. Mousa, Jawed Fareed, Omer Iqbal, and Brigitte Kaiser Cell Adhesion Molecules: Potential Therapeutic and Diagnostic Implications Shaker A. Mousa Development and Applications of Animal Models of Thrombosis Ronald J. Shebuski, Larry R. Bush, Alison Gagnon, Liguo Chi, and Robert J. Leadley, Jr. A Survey of Venous Thrombosis Models Walter P. Jeske, Omer Iqbal, Jawed Fareed, and Brigitte Kaiser Arixtra(R) (Fondaparinux Sodium) Shaker A. Mousa Oral Thrombin Inhibitor Ximelagatran Shaker A. Mousa Pharmacogenomics and Coagulation Disorders Omer Iqbal Guidelines for Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Hikmat Abdel-Razeq, Mohamad Qari, Jorgen Kristensen, Hussein Alizeidah, Faisal Al-Sayegh, Mahmoud Marashi, Abdulaziz Alzeer, Omar Al-Amoudi, Hatem Qutub, Abdel-Aziz Al-Humiadi, Steen Husted, and Shaker A. Mousa on behalf of the GCC Thrombosis Study Group Index